Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Biographical Sketch
Thomas Kuivila, MD, is Staff Physician, Pediatric Orthopaedic Surgery, Department of Orthopaedic Surgery at Cleveland Clinic. He currently heads the Section of Pediatric and Adolescent Spinal Disorders in the Orthopaedic and Rheumatology Institute and is the Residency Program Director in Orthopaedic Surgery.
Dr. Kuivila’s special interests include congenital and developmental spinal disorders to include scoliosis, kyphosis and sponylolysis and lithesis. He is also an expert in pediatric orthopaedic traumatology. His research interests include bioabsorbable fixation and minimally invasive scoliosis surgery.
He did his orthopaedic surgery residency at Cleveland Clinic, served as an A-O international orthopaedic traumatology fellow in Graz, Austria and was a pediatric orthopaedic surgery fellow at Brown University and Rhode Island Hospital in Providence, R.I. Dr. Kuivila then spent six years in the United States Air Force Medical Corps. There, he served as Orthopaedic Department Chairman at Keesler U.S.A.F. Medical Center in Biloxi, Miss., and subsequently as the Chief of Pediatric Orthopaedic Surgery at Wilford Hall U.S.A.F. Medical Center in San Antonio, Tex.
While in San Antonio, he was also the U.S.A.F. residency program director in orthopaedic surgery and a consultant to the Air Force Surgeon General. Dr. Kuivila brings to the department considerable experience and expertise in the management of complex acquired and congenital pediatric and adolescent orthopaedic disorders of the spine and extremities.
Specialty Interests
CPediatric, Adolescent and Young Adult Spinal Surgery; Pediatric Orthopaedic Trauma and Post-Traumatic Deformity
Awards & Honors
Best Doctors in America, Pediatric Orthopaedic Surgery, 2003-2011
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 3/12/2010,
Dr. Kuivila has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
